glp 1 blue cross Independence to stop covering GLP-1 agonists Wegovy, Ozempic as weight loss drugs in 2025 IBX joins other insurers in

MonamiMNreuBScatenaAGianniniSAndreozziFSestiGet alGlucagon-like peptide-1 receptor agonists and atrial fibrillation: a systematic review and meta-analysis of randomised controlled trials

One 2024 study in Cell Metabolism showed that a single low dose of GLP-1 reduces inflammation, independent of weight loss

It helps you collect the right history, screen safety risks early, and route each patient to the correct next step before you invest provider time

In healthy individuals, insulin facilitates vasodilation and enhances blood flow to skeletal muscles, which correlates with increased glucose uptake (Steinberg and Baron, 2002)

But the model covers only a fraction of the population that could benefit